CHARLES SCHWAB INVESTMENT MANAGEMENT INC - XILIO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of XILIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,162
-19.5%
11,9250.0%0.00%
Q2 2023$31,244
-72.6%
11,925
-25.9%
0.00%
Q1 2022$114,000
-55.8%
16,1000.0%0.00%
Q4 2021$258,00016,1000.00%
Other shareholders
XILIO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,441,444$3,041,4477.52%
Trustees of Columbia University in the City of New York 249,635$526,7300.97%
Atlas Venture Life Science Advisors, LLC 2,759,344$5,822,2160.90%
Octagon Capital Advisors LP 2,318,500$4,892,0350.75%
Bain Capital Life Sciences Investors, LLC 2,805,413$5,919,4210.66%
HARVARD MANAGEMENT CO INC 416,059$8780.10%
Rock Springs Capital Management LP 1,440,759$3,040,0010.08%
Soleus Capital Management, L.P. 226,941$478,8460.04%
Artal Group S.A. 450,000$9500.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,481$233,1150.01%
View complete list of XILIO THERAPEUTICS INC shareholders